Confidently Navigating ADPKD: Understanding the New KDIGO Guideline, Decoding ADPKD: Managing ADPKD - Treatments, Lifestyle, & Living Well - Polycystic kidney disease | PKD treatment research

ADPKD affects more than just the kidneys. In part three of our four-part series, we’ll explore how ADPKD impacts the heart, liver, bones, and metabolic health.

Learning Objectives:

Heart and vascular risks in ADPKD, including brain aneurysms.
Polycystic liver disease (PLD) and how to manage symptoms.
The impact of ADPKD on bone health, metabolism, and urinary health.
Preventive care strategies for whole-body health

Speakers: Craig Gordon, M.D., M.S.: Director of the PKD Foundation Center of Excellence at Tufts Medical Center Pranav Garimella, MBBS, MPH, FASN: Director of the PKD Foundation Center of Excellence at University of California San Diego

*The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Guidelines for ADPKD provide the latest evidence-based recommendations to help patients, caregivers, and healthcare providers navigate the complexities of autosomal dominant polycystic kidney disease (ADPKD). Our 4-part educational series is designed to help patients and families better understand the latest KDIGO recommendations for ADPKD management.

This webinar is supported by a sponsorship from Otsuka. The PKD Foundation retains full control over the content and speaker selection to ensure unbiased, high-quality education for our community.